Last edition
News about Market
Pharmexcil Urges Exporters to Respond to Urgent Pharmaceutical Request from Mauritius
Pharmexcil has shared a comprehensive list of 40 medicines sought by Mauritius, which are used in the treatment of leprosy, malaria, tuberculosis (TB), asthma, and bacterial infections of the eye, ear, and skin.
Market | 13/07/2025 | By Darshana | 203
Varda Space Industries has announced the successful closure of a USD 187 million Series C funding round, increasing its total capital raised to USD 329 million.
Market | 11/07/2025 | By Darshana | 264
Ofichem Group Acquires Avivia to Bolster Complex Formulation Capabilities
Avivia is known for its focus on preformulation, formulation, and analytical method development for challenging pharmaceutical products. The acquisition aligns with Ofichem’s broader strategy to become a fully integrated CDMO, offering end-to-end services from active pharmaceutical ingredient (API) development to GMP manufacturing.
Market | 11/07/2025 | By Darshana | 400
Endometriosis Market to Triple by 2034, Driven by Novel Therapies and Rising Diagnoses: GlobalData
This robust growth is attributed to the expected launch of innovative therapies such as Kissei Pharmaceutical’s Yselty (linzagolix), a GnRH antagonist already available in Europe and soon launching in the US and Japan.
Market | 04/07/2025 | By Darshana | 248
Cadila Pharmaceuticals Launches Bilacad Dex Syrup
Cadila Pharmaceuticals has announced the launch of Bilacad Dex Syrup, to address the increasing burden of respiratory and allergy-related conditions with a novel fixed-dose combination of Bilastine, Dextromethorphan, and Phenylephrine.
Market | 01/07/2025 | By Darshana | 184
Escala Medical Raises USD 4.5 Million to Boost US Expansion
The funds will be used to expand Escala's commercial operations in the US, where the company's flagship device has been FDA-approved and commercially launched in 2023.
Market | 01/07/2025 | By Manvi | 199
India’s growing pharmaceutical trade with Venezuela is underpinned by the Latin American country's demand for cost-effective and high-quality generic medicines. Pharmexcil has circulated the list of required drugs to eligible manufacturers and urged prompt responses through a designated Google form.
Market | 01/07/2025 | By Darshana | 418
Nanoform Secures EUR 5 Million R&D Loan from Business Finland
Nanoform Finland Plc has secured an EUR 5 million R&D loan from Business Finland to advance the clinical development of nanoapalutamide, its proprietary nanocrystalline formulation of apalutamide aimed at improving patient adherence and offering a more sustainable alternative to traditional prostate cancer treatments.
Market | 23/06/2025 | By Manvi | 112
Biocon Raises INR 4,500 Crore Through QIP
Biocon has successfully raised INR 4,500 crore through a Qualified Institutions Placement (QIP) through the issuance of 13,63,63,635 equity shares of face value 5 each to eligible qualified institutional buyers at the issue price of INR 330 per equity share.
Market | 21/06/2025 | By Manvi | 157
India's Pharma Exports Continue Upward Trajectory With 7.4% Growth in May
In Rupee terms, the export value rose by 9.69%, reaching Rs. 21,090 crore, compared to Rs. 19,227 crore in the same month last year. The increase highlights the continued global demand for Indian pharmaceutical products, especially in key markets such as the US, Europe, and emerging economies.
Market | 19/06/2025 | By Darshana | 1357
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy